Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?

Oncology
Evagellos LiberopoulosMoses Elisaf

Abstract

Tamoxifen has favorable effects on the serum lipid profile. It has been suggested that the apolipoprotein (Apo) E phenotype can influence serum lipid parameters; the ApoE allele 4 (ApoE4) is associated with higher total and low-density lipoprotein (LDL) cholesterol levels. The ApoE phenotype also affects lipid responses to diets or treatment with statins. However, the effect of tamoxifen on the lipid profile in different ApoE phenotypes is unknown. In the present study, we evaluated the effects of tamoxifen on the serum lipid profile in 11 ApoE4-positive postmenopausal women with breast cancer (phenotypes 3/4 and 4/4) compared with 33 ApoE4-negative women (phenotypes 3/2 and 3/3). Serum lipid parameters [high-density (HDL), LDL and total cholesterol, triglycerides, ApoAI, ApoB and lipoprotein (a)] were measured after an overnight fast before treatment and after 3 and 12 months. ApoE isoforms were determined by isoelectric focusing of delipidated very-low-density lipoproteins (VLDL). During the follow-up period, serum levels of total and LDL cholesterol and ApoB decreased significantly in both groups, but no significant differences were found. Concentrations of serum HDL cholesterol were not significantly different between both ...Continue Reading

Citations

Jun 17, 2003·Clinical Obstetrics and Gynecology·Michael W Draper, William W Chin
Jul 1, 2005·Future Cardiology·Christos S KatsourasAlexandros D Tselepis
Jan 6, 2011·Expert Opinion on Investigational Drugs·Giovanni GaetaGiancarlo Vitagliano
Dec 24, 2008·Clinica Chimica Acta; International Journal of Clinical Chemistry·Nai-Wen ChangDar-Ren Chen
Nov 18, 2008·Cancer Treatment Reviews·T D FilippatosD P Mikhailidis
Jan 30, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Evagelos LiberopoulosMoses Elisaf
Feb 21, 2003·Angiology·Genovefa KolovouDimitri P Mikhailidis
Oct 24, 2006·Journal of Cardiovascular Pharmacology and Therapeutics·Dimitrios S ChristidisMoses S Elisaf
Oct 25, 2003·Oncogene·Robert ClarkeLeena A Hilakivi-Clarke
Jul 6, 2013·The International Journal of Biological Markers·María GaibarAna Fernández-Santander
Sep 19, 2006·Drugs·Kathleen I Pritchard, Beth L Abramson

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.